Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses

An HIV-1 vaccine remains elusive, in part because various factors limit the quantity and quality of the antibodies raised against the viral envelope glycoprotein complex (Env). We hypothesized that targeting Env vaccines directly to B cells, by fusing them to molecules that bind and activate these c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Melchers, Mark, Bontjer, Ilja, Tong, Tommy, Chung, Nancy P. Y., Klasse, Per Johan, Eggink, Dirk, Montefiori, David C., Gentile, Maurizio, Cerutti, Andrea, Olson, William C., Berkhout, Ben, Binley, James M., Moore, John P., Sanders, Rogier W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2012
Konular:
Vaccines and Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302291/
https://ncbi.nlm.nih.gov/pubmed/22205734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.06259-11
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller